Analyst firms · Morgan Stanley · RPID
Morgan Stanley RPID price target and rating history
Rapid Micro Biosystems Inc. (RPID) · Health Care
Morgan Stanley rates Rapid Micro Biosystems Inc. (RPID) Equal-Weight with a $10 price target, as of its latest action on Mar 7, 2022. It has published 4 rating actions on RPID since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Equal-Weight
- Price target
- $10
- Median target, all firms
- Too few
- Actions on RPID
- 4
Morgan Stanley price target on RPID
Every Morgan Stanley rating on RPID
- Mar 7, 2022
- Feb 15, 2022
- Nov 15, 2021
- Aug 9, 2021
Questions about Morgan Stanley and RPID
- What is Morgan Stanley's price target for RPID?
- Morgan Stanley's latest stated price target for Rapid Micro Biosystems Inc. (RPID) is $10, from its action on Mar 7, 2022.
- What is Morgan Stanley's rating on RPID?
- Morgan Stanley rates RPID Equal-Weight, a neutral rating, as of Mar 7, 2022.
- When did Morgan Stanley last change its view on RPID?
- On Mar 7, 2022, Morgan Stanley cuts its price target to $10 from $11, keeps Equal-Weight.
All Morgan Stanley ratingsRPID news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.